MedTrace Logo

Evaluation of Metronidazole Hydrogel 25% in Stage II and III Periodontitis

NCT04983849 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-12-12

No results posted yet for this study

Summary

A randomized clinical trial will be performed single-blind to evaluate the effectiveness of sublingual metronidazole hydrogel 25 % in periodontitis.

Conditions

  • Periodontitis

Interventions

DRUG

metronidazole hydrogel

scaling and root planning in adjunct to the use of metronidazole in the periodontal pocket

PROCEDURE

scaling and root planning

scaling and root planning

Sponsors & Collaborators

  • University of L'Aquila

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2021-07-07
Completion
2021-07-07

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04983849 on ClinicalTrials.gov